How did AZN's Q4 2024 earnings surprise impact its stock?

AstraZeneca's (AZN) Q4 2024 earnings surprise had a negative impact on its stock. The company reported a diluted EPS of $0.96 for the quarter, which represents a decrease of 1.35% from the previous quarter's EPS of $1.24. This decline in EPS was coupled with a total revenue of $14.89 billion, which is a 4.02% surprise over the Zacks Consensus Estimate of $13.04 billion. However, the market seemed to react more to the EPS decline than the revenue surprise.

The negative surprise in EPS likely contributed to the stock's performance, as investors may have had concerns about the company's profitability and future growth prospects. The stock price of AZN decreased by 1.35% on April 8, 2025, reflecting the market's reaction to the earnings surprise.